Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients—A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial
Nutrients · 16.05.2024 · 16 (10) · 1503
DOI: 10.3390/nu16101503 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 16.05.2024. Verfasst von Henning Sommermeyer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Calisia University, Nowy Swiat 4, 62-800 Kalisz, Poland. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Synbiotics. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The aim of the study was to characterize effects of a multi-strain synbiotic in patients with moderate to severe irritable bowel syndrome (IBS) of all stool form types. A total of 202 adult IBS patients were randomized (1:1) and after a four-week treatment-free run-in phase and were treated either with the synbiotic or a placebo for 12 weeks. The primary endpoints were the assessment of the severity of IBS symptoms (IBS-SSS) and the improvement of IBS global symptoms (IBS-GIS). Secondary endpoints comprised adequate relief (IBS-AR scale), stool form type (Bristol Stool Form Scale), bowel movements, severity of abdominal pain and bloating, stool pressure, feeling of incomplete stool evacuation, and adverse events. A total of 201 patients completed the study. Synbiotic treatment, in comparison to placebo, significantly improved IBS-SSS and IBS-GIS scores. At the end of the treatment, 70% of patients in the synbiotic group achieved adequate relief. After 12 weeks of treatment, the secondary endpoints were favorably differentiated in the synbiotic group when compared with the placebo group. Two patients in the synbiotic group reported transient adverse events (headache). The results indicate that treatment of IBS patients with the synbiotic significantly improved all major symptoms of IBS and was well-tolerated. The ClinicalTrials.gov registration was NCT05731232.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences, Calisia University, Nowy Swiat 4, 62-800 Kalisz, Poland.
- Department of Hygiene and Epidemiology, Collegium Medicum, University of Zielona Góra, 28 Zyty St., 65-046 Zielona Góra, Poland.
ORCID-Profile: Krzysztof Chmielowiec, Jacek Piątek
Zitieren
APA
Sommermeyer, H., Chmielowiec, K., Bernatek, M., Olszewski, P., Kopczynski, J., & Piątek, J. (2024). Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients—A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 16(10), 1503. https://doi.org/10.3390/nu16101503
Vancouver
Sommermeyer H, Chmielowiec K, Bernatek M, Olszewski P, Kopczynski J, Piątek J. Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients—A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2024;16(10):1503. doi:10.3390/nu16101503
BibTeX
@article{Sommermeyer2024,
author = {Sommermeyer, Henning and Chmielowiec, Krzysztof and Bernatek, Malgorzata and Olszewski, Pawel and Kopczynski, Jaroslaw and Piątek, Jacek},
title = {Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients—A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {10},
pages = {1503},
doi = {10.3390/nu16101503}
}
EUVIMED